Direct Vasodilator Flashcards
PDE 5 inhibitors MOA
breaks down cGMP, the more cGMP, the more relaxation
PDE 5 inhibitors drugs
Sildenafil, Tadalafil, Vardenafil, Avanafil
PDE 5 inhibitor therapeutic effects
benefit in erectile dysfunction, BPH, pulmonary arterial hypertension
PDE 3 inhibitor: Milirinone
Inhibit PDE 3, which results in more cAMP, which increases the Force of Contraction
PDE 3 Inhibitor Therapeutic Use
short term IV treatment for patients with acute decompensated Heart failure
ADR of PDE 3 inhibitor
ventricular arrhythmias (<48 hr), Hepatotoxicity, Thrombocytopenia, headache, HYPOkalemia, tremor
Nitrates MOA
Converts to Nitric Oxide, stimulates increase of cGMP to promote smooth muscle relaxation
Nitrates therapeutic use
reduces myocardial oxygen demand and angina management
Nitrates ADRs
Headache, flushing, rash, dizziness, sweating, general hypotension, methemoglobinemia
Don’t combine PDE 5 and Nitrates
too much cGMP will result in too much vasodilation and therefore orthostatic hypotension
Nitroglycerin
IV used for Acute CHF, Angina, MI, severe hypertension (SL tab)
Isosorbide dinitrate (ISDN)
PO tab for angina
Isosorbide mononitrate
PO tab for angina
Minoxidil MOA
Direct potent vasodilator of arterial smooth muscle
Minoxidil Therapeutic Uses
treat for severe drug resistant hypertension
Minoxidil ADRs
hypotension, hypertrichosis, sinus tachycardia, angina, headache, peripheral edema, fluid retention
Hydralazine MOA
direct, potent vasodilation of arterial smooth muscle, decreased BP
Hydralazine Therapeutic Use
Hypertension Emergency
Hydralazine ADR
Reflex Tachycardia, hypotension, Fluid Retention
Hydralazine and ISDN
BiDil, useful for African American Patients who have heart failure but cannot take ACEI/ARB
Minoxidil potency
Most potent, combine with loop diuretic and beta blocker
Nitroprusside MOA
Direct potent vasodilator on arterial/venous smooth muscle; liberates NO
Nitroprusside Therapeutic Uses
IV only; Hypertensive Emergency, Acute CHF
Nitroprusside ADRs
Hypotension; Methemoglobinemia
Digoxin MOA
Competitively binds to K site on Na/K channel; increases intracellular Na, which increases intercellular Ca, causes more contractions
Digoxin Therapeutic Uses
CHF; rate control in atrial fibrillation; improves LVEF symptoms
Digoxin ADRs
“Digitalis Toxicity”, HYPER-Kalemia, AV block, Arrythmias, EKG change, Xanthopsia, Digiband/Digifac